---
title: "Cero Therapeutics Secures $2.09M 10% Convertible Note With SRX Global, Maturing May 2027"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293073319.md"
description: "Cero Therapeutics secured a fully funded $2.09M convertible note from SRX Global, maturing May 2027 with 10% interest. Conversion occurs at the lesser of $0.05 or 80% of the average of the five lowest intraday prices over the prior 20 days, subject to a 4.99% ownership cap. The company plans to file an S-1 or S-3 to register resale of conversion shares."
datetime: "2026-07-17T20:43:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293073319.md)
  - [en](https://longbridge.com/en/news/293073319.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293073319.md)
generator: "portal-rs"
---

# Cero Therapeutics Secures $2.09M 10% Convertible Note With SRX Global, Maturing May 2027

Cero Therapeutics entered into a second amended and restated convertible promissory note with SRX Global for up to $2,085,200, now fully funded. The note bears 10% interest and matures on May 28, 2027, with conversion at the lesser of $0.05 or 80% of the average of the five lowest intraday prices over the prior 20 days, subject to a 4.99% ownership cap. Tranches were funded on May 23, June 23, and July 14, 2026. The company will file an S-1 or S-3 to register the resale of conversion shares.

**Agreement details:**

-   **Agreement type**: Second amended and restated convertible promissory note
-   **Counterparty**: SRX Global
-   **Signed / Effective**: Jul 14 2026 / same
-   **Duration / Termination**: Through May 28 2027
-   **Reason**: Enhance liquidity and funding flexibility

Original SEC Filing: CERO THERAPEUTICS HOLDINGS, INC. \[ CERO \] - 8-K - Jul. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CERO.US](https://longbridge.com/en/quote/CERO.US.md)
- [SRXH.US](https://longbridge.com/en/quote/SRXH.US.md)
- [CEROW.US](https://longbridge.com/en/quote/CEROW.US.md)

## Related News & Research

- [CERo Therapeutics Secures Up to $11.67 Million SRX Financing, Consolidates $5.67 Million Debt](https://longbridge.com/en/news/297561416.md)
- [SRX Global buys senior secured debt in CERo Therapeutics Holdings](https://longbridge.com/en/news/297509635.md)
- [ENRGY: Record revenue and profit growth, with 90% of 2027 EBITDA already secured](https://longbridge.com/en/news/297895804.md)
- [SRX Global buys senior secured debt in CERo Therapeutics Holdings](https://longbridge.com/en/news/297829391.md)
- [SRX Global sells 3,579 Series C preferred shares in private placement valued at $2.86 million](https://longbridge.com/en/news/297369039.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**